
Paul V. Ward
Examiner (ID: 4583)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1622, 1623 |
| Total Applications | 2519 |
| Issued Applications | 1801 |
| Pending Applications | 239 |
| Abandoned Applications | 539 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10821965
[patent_doc_number] => 20160168129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'QUINAZOLINE DERIVATIVES, COMPOSITIONS THEREOF, AND USE AS PHARMACEUTICALS'
[patent_app_type] => utility
[patent_app_number] => 14/905619
[patent_app_country] => US
[patent_app_date] => 2014-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11555
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905619
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/905619 | Quinazoline derivatives, compositions thereof, and use as pharmaceuticals | Jul 16, 2014 | Issued |
Array
(
[id] => 9799699
[patent_doc_number] => 20150011643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'TREATMENT OF HEART FAILURE AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/332234
[patent_app_country] => US
[patent_app_date] => 2014-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4999
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14332234
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/332234 | TREATMENT OF HEART FAILURE AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS | Jul 14, 2014 | Abandoned |
Array
(
[id] => 12491022
[patent_doc_number] => 09994954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Volatile dihydropyrazinly and dihydropyrazine metal complexes
[patent_app_type] => utility
[patent_app_number] => 14/329323
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 7062
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14329323
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/329323 | Volatile dihydropyrazinly and dihydropyrazine metal complexes | Jul 10, 2014 | Issued |
Array
(
[id] => 10987365
[patent_doc_number] => 20160184310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/909365
[patent_app_country] => US
[patent_app_date] => 2014-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24260
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909365
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909365 | Oxoquinazolinyl-butanamide derivatives | Jul 9, 2014 | Issued |
Array
(
[id] => 10248443
[patent_doc_number] => 20150133439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/327312
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7097
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327312
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/327312 | QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS | Jul 8, 2014 | Abandoned |
Array
(
[id] => 10975449
[patent_doc_number] => 20140378484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES'
[patent_app_type] => utility
[patent_app_number] => 14/317912
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 28754
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14317912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/317912 | Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses | Jun 26, 2014 | Issued |
Array
(
[id] => 10103804
[patent_doc_number] => 09139577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Sulfoximine substituted quinazolines for pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 14/315399
[patent_app_country] => US
[patent_app_date] => 2014-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36901
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315399
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/315399 | Sulfoximine substituted quinazolines for pharmaceutical compositions | Jun 25, 2014 | Issued |
Array
(
[id] => 10007826
[patent_doc_number] => 09051327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases'
[patent_app_type] => utility
[patent_app_number] => 14/307680
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119127
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14307680
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/307680 | Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases | Jun 17, 2014 | Issued |
Array
(
[id] => 11018034
[patent_doc_number] => 20160214986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/898327
[patent_app_country] => US
[patent_app_date] => 2014-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85654
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898327
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/898327 | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | Jun 11, 2014 | Issued |
Array
(
[id] => 11908191
[patent_doc_number] => 09776995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Bicyclic sulfonamide compounds as sodium channel inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/898070
[patent_app_country] => US
[patent_app_date] => 2014-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 186430
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898070
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/898070 | Bicyclic sulfonamide compounds as sodium channel inhibitors | Jun 10, 2014 | Issued |
Array
(
[id] => 11698784
[patent_doc_number] => 09688687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Polymorphic forms of icotinib phosphate and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/896706
[patent_app_country] => US
[patent_app_date] => 2014-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7388
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896706
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896706 | Polymorphic forms of icotinib phosphate and uses thereof | Jun 8, 2014 | Issued |
Array
(
[id] => 11462711
[patent_doc_number] => 09579326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Theramutein modulators'
[patent_app_type] => utility
[patent_app_number] => 14/297863
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27220
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297863
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/297863 | Theramutein modulators | Jun 5, 2014 | Issued |
Array
(
[id] => 11805169
[patent_doc_number] => 09546180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-17
[patent_title] => 'Heterocyclic compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/297526
[patent_app_country] => US
[patent_app_date] => 2014-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99780
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297526
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/297526 | Heterocyclic compounds and uses thereof | Jun 4, 2014 | Issued |
Array
(
[id] => 11010975
[patent_doc_number] => 20160207928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/896450
[patent_app_country] => US
[patent_app_date] => 2014-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37344
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896450 | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER | Jun 3, 2014 | Abandoned |
Array
(
[id] => 10920705
[patent_doc_number] => 20140323725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'PROCESSES OF SYNTHESIZING DIHYDROPYRIDOPHTHALAZINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/293642
[patent_app_country] => US
[patent_app_date] => 2014-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7399
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14293642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/293642 | Processes of synthesizing dihydropyridophthalazinone derivatives | Jun 1, 2014 | Issued |
Array
(
[id] => 10791490
[patent_doc_number] => 20160137646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'Novel Compounds and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/894214
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100461
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894214 | Compounds for treatment of diseases of abnormal angiogenesis or aberrant growth factors and uses thereof | May 29, 2014 | Issued |
Array
(
[id] => 10693643
[patent_doc_number] => 20160039789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/289239
[patent_app_country] => US
[patent_app_date] => 2014-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49567
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14289239
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/289239 | SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF | May 27, 2014 | Abandoned |
Array
(
[id] => 11663521
[patent_doc_number] => 20170152241
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-06-01
[patent_title] => 'BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/893517
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44851
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893517
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893517 | BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR | May 22, 2014 | Abandoned |
Array
(
[id] => 11663521
[patent_doc_number] => 20170152241
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-06-01
[patent_title] => 'BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/893517
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44851
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893517
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893517 | BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR | May 22, 2014 | Abandoned |
Array
(
[id] => 10103821
[patent_doc_number] => 09139595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Biologically active macrolides, compositions, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/275336
[patent_app_country] => US
[patent_app_date] => 2014-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26540
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14275336
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/275336 | Biologically active macrolides, compositions, and uses thereof | May 11, 2014 | Issued |